相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Amphetamine-like Neurochemical and Cardiovascular Effects of α-Ethylphenethylamine Analogs Found in Dietary Supplements
Charles W. Schindler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)
A Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020
Nunzia La Maida et al.
THERAPEUTIC DRUG MONITORING (2021)
Behavioral Effects of 4-CMC and 4-MeO-PVP in DBA/2J Mice After Acute and Intermittent Administration and Following Withdrawal from Intermittent 14-Day Treatment
Jakub Wojcieszak et al.
NEUROTOXICITY RESEARCH (2021)
Reinforcing and discriminative-stimulus effects of two pyrrolidine-containing synthetic cathinone derivatives in rats
Peng Xu et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2021)
An updated review on synthetic cathinones
Jorge Soares et al.
ARCHIVES OF TOXICOLOGY (2021)
Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics
Deborah Rudin et al.
EXPERIMENTAL NEUROLOGY (2021)
Behavioral effects of four novel synthetic cathinone analogs in rodents
Michael B. Gatch et al.
ADDICTION BIOLOGY (2021)
Stereoselective neurochemical, behavioral, and cardiovascular effects of α-pyrrolidinovalerophenone enantiomers in male rats
Charles W. Schindler et al.
ADDICTION BIOLOGY (2020)
Methamphetamine-related cardiovascular diseases
Valentin Schwarzbach et al.
ESC HEART FAILURE (2020)
Hyperthermia Increases Neurotoxicity Associated with Novel Methcathinones
Xun Zhou et al.
CELLS (2020)
Four Synthetic Cathinones: 3-Chloromethcathinone, 4-Chloromethcathinone, 4-Fluoro-α-Pyrrolidinopentiophenone, and 4-Methoxy-α-Pyrrolidinopentiophenone Produce Changes in the Spontaneous Locomotor Activity and Motor Performance in Mice with Varied Profiles
Jakub Wojcieszak et al.
NEUROTOXICITY RESEARCH (2020)
The Supplement Adulterant β-Methylphenethylamine Increases Blood Pressure by Acting at Peripheral Norepinephrine Transporters
Charles W. Schindler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones
Dino Luethi et al.
FRONTIERS IN PHARMACOLOGY (2019)
Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats
Chloe J. Jordan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomes
Bruce E. Blough et al.
PSYCHOPHARMACOLOGY (2019)
Blood concentrations of a new psychoactive substance 4-chloromethcathinone (4-CMC) determined in 15 forensic cases
Ewa Tomczak et al.
FORENSIC TOXICOLOGY (2018)
Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats
Brenda M. Gannon et al.
NEUROPHARMACOLOGY (2018)
The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter
Brenda M. Gannon et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone)
Marc Grifell et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2017)
The Cardiovascular Effects of Cocaine
Ofer Havakuk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse Liability
Ernesto Solis et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release
Amy J. Eshleman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Contribution of serotonin and dopamine to changes in core body temperature and locomotor activity in rats following repeated administration of mephedrone
Sinead E. Shortall et al.
ADDICTION BIOLOGY (2016)
Pharmacological mechanisms underlying the cardiovascular effects of the bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV)
Charles W. Schindler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Human Pharmacology of Mephedrone in Comparison with MDMA
Esther Papaseit et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues
J. S. Bonano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues
F. Sakloth et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
'Second-Generation' Mephedrone Analogs, 4-MEC and 4-MePPP, Differentially Affect Monoamine Transporter Function
Kusumika Saha et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines
Michael H. Baumann et al.
JOURNAL OF NEUROSCIENCE (2014)
Pharmacology of novel synthetic stimulants structurally related to the bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)
Julie A. Marusich et al.
NEUROPHARMACOLOGY (2014)
Hybrid Dopamine Uptake Blocker-Serotonin Releaser Ligands: A New Twist on Transporter-Focused Therapeutics
Bruce E. Blough et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Deconstruction of the Abused Synthetic Cathinone Methylenedioxypyrovalerone (MDPV) and an Examination of Effects at the Human Dopamine Transporter
Renata Kolanos et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Substituted methcathinones differ in transporter and receptor interactions
Amy J. Eshleman et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Pharmacological characterization of designer cathinones in vitro
L. D. Simmler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia
S. E. Shortall et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Sympathomimetic syndrome, choreoathetosis, and acute kidney injury following âbath saltsâ injection
Grerk Sutamtewagul et al.
CLINICAL NEPHROLOGY (2013)
Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone)
M. L. Miller et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Amphetamine, past and present - a pharmacological and clinical perspective
David J. Heal et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products
Michael H. Baumann et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats
Kurt J. Varner et al.
PSYCHOPHARMACOLOGY (2013)
Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation
Renata Lisek et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue
Michael H. Baumann et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats
J. Kehr et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Clinical experience with and analytical confirmation of bath salts and legal highs (synthetic cathinones) in the United States
Henry A. Spiller et al.
CLINICAL TOXICOLOGY (2011)
Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service
D. James et al.
EMERGENCY MEDICINE JOURNAL (2011)
4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse
Gregory C. Hadlock et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool
BJ Venton et al.
JOURNAL OF NEUROSCIENCE (2006)
Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon
KK Chadman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates
RB Rothman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
分享论文
